GLP‑1, a hormone that signals satiety, has attracted Nobel‑level attention after Clarivate Analytics ranked its research as the top contender for the 2026 Chemistry Prize. The award, which will be announced by the Royal Swedish Academy of Sciences at 11:45 am in Stockholm, follows a tradition of honoring breakthroughs that reshape entire fields. Other frontrunners highlighted by Clarivate include the design of self‑assembled monolayers—molecular coatings that tailor surface properties—and precision gene‑editing tools that can rewrite DNA in living cells. David Pendlebury, head of research analysis at Clarivate, told AFP that the GLP‑1 work "could receive a chemistry prize," citing its impact on metabolic disease treatment. In Delhi, a 47‑year‑old teacher named Meera Sharma began using Wegovy last month to combat obesity, hoping the science behind GLP‑1 will one day earn global recognition. The Nobel laureates will be revealed Thursday, and the prize—worth 12 million Swedish kronor, shared if multiple winners—could shape the future of drug development.